Abstract:The percentage of airway CTLA-4+CD4+CD25+ cells increased after FP treatment, coincident with improvements in airway inflammation and hyperresponsiveness.Whether improved asthma assessments are related to the increase in CTLA-4+CD4+CD25+ cells and thus improved regulation of T-cell tolerance and differentiation will require a larger sample size to determine. The normalization of CTLA-4+CD4+CD25+ cells in asthma may contribute to the management of this disease.
“…The effect of inhaled steroids on these suppressor cells was tested in a 14-day, placebo controlled trial of 11 mild asthmatics given inhaled fluticasone. 17 Fluticasone increased the number of CTLA-4+CD4+CD25+ cells in sputum. While bronchial hyper-responsiveness and sputum eosinophilia also improved with fluticasone, these improvements did not correlate with the increase in CTLA-4+CD4+CD25+ cells.…”
Section: Treatment Effects In Asthmamentioning
confidence: 96%
“…Cytotoxic T‐lymphocyte antigen (CTLA)‐4 is a marker of activated T cells. The effect of inhaled steroids on these suppressor cells was tested in a 14‐day, placebo controlled trial of 11 mild asthmatics given inhaled fluticasone 17 . Fluticasone increased the number of CTLA‐4+CD4+CD25+ cells in sputum.…”
“…The effect of inhaled steroids on these suppressor cells was tested in a 14-day, placebo controlled trial of 11 mild asthmatics given inhaled fluticasone. 17 Fluticasone increased the number of CTLA-4+CD4+CD25+ cells in sputum. While bronchial hyper-responsiveness and sputum eosinophilia also improved with fluticasone, these improvements did not correlate with the increase in CTLA-4+CD4+CD25+ cells.…”
Section: Treatment Effects In Asthmamentioning
confidence: 96%
“…Cytotoxic T‐lymphocyte antigen (CTLA)‐4 is a marker of activated T cells. The effect of inhaled steroids on these suppressor cells was tested in a 14‐day, placebo controlled trial of 11 mild asthmatics given inhaled fluticasone 17 . Fluticasone increased the number of CTLA‐4+CD4+CD25+ cells in sputum.…”
“…A randomized double-blind, cross-over, placebo control trial investigated whether treatment with ICS (Fluticasone propionate, GSK, Japan) could increase the population of sputum CTLA4 + Tregs, decrease sputum eosinophils, and increase interleukin (IL)-10 ( Figure 6) [41]. The effect of ICS on Foxp3 + Tregs has not yet been investigated in patients with asthma.…”
Section: Efficacy Of Ics On Airway Tregs In Patients With Asthmamentioning
confidence: 99%
“…* p<0.05 versus pre-treatment. B) Comparison of changes in IL-10, TGF-β1 and IL-13 levels of sputum supernatants between ICS and placebo [41]. Data were expressed as mean (SEM).…”
Section: Fig 6 Sputum Regulatory T Cells In Mild Asthmatics After Tmentioning
“…1,2 Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a member of the immunoglobulin gene superfamily and plays an important role in the downregulation of the T-cell response, T-cell homeostasis and maintenance of peripheral tolerance. 3 However, no data are available concerning the potentially important relationship between COPD and CTLA-4. This study aimed to investigate the relationships between serum levels of soluble CTLA-4 in COPD patients and lung function and inflammation.…”
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is involved in immune and inflammation regulation. The present study aimed to investigate the association between CTLA-4 and COPD. Data revealed that serum levels of CTLA-4 were elevated in COPD patients, inversely correlated with lung function and positively correlated with serum C-reactive protein levels in the COPD group. These findings suggest that CTLA-4 may play a role in COPD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.